Table 3. P values of the test ${\mathit{H}}_{\mathbf{0}}\mathbf{:}{\overline{\mathbf{\beta }}}_{\mathbf{3}}\mathbf{=}\mathbf{0}$ using model (2) and ${\mathit{H}}_{\mathbf{0}}^{\prime }\mathbf{:}{\tilde{\mathbf{\beta }}}_{\mathbf{2}}\mathbf{=}\mathbf{0}$ using model (3) for all three comparisons under oral administration.

Three comparisons under oral administration.

Pairwise comparison	${\mathit{H}}_{\mathbf{0}}\mathbf{:}{\overline{\mathbf{\beta }}}_{\mathbf{3}}\mathbf{=}\mathbf{0}$	${\mathit{H}}_{\mathbf{0}}^{\prime }\mathbf{:}{\tilde{\mathbf{\beta }}}_{\mathbf{2}}\mathbf{=}\mathbf{0}$
Untreated versus carprofen	0.13827	0.014
Untreated versus PLGA-GA2-CUR	0.87049	0.00483
Carprofen versus PLGA-GA2-CUR	0.15326	0.7270